A phase I dose escalation study of AT9283, a small molecule inhibitor of aurora kinases, in patients with advanced solid malignancies
出版年份 2011 全文链接
标题
A phase I dose escalation study of AT9283, a small molecule inhibitor of aurora kinases, in patients with advanced solid malignancies
作者
关键词
-
出版物
ANNALS OF ONCOLOGY
Volume 23, Issue 5, Pages 1307-1313
出版商
Oxford University Press (OUP)
发表日期
2011-10-21
DOI
10.1093/annonc/mdr451
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Essential Roles of mTOR/Akt Pathway in Aurora-A Cell Transformation
- (2012) Makoto Taga et al. International Journal of Biological Sciences
- A phase I pharmacokinetic and pharmacodynamic study of AT7519, a cyclin-dependent kinase inhibitor in patients with refractory solid tumors
- (2011) D. Mahadevan et al. ANNALS OF ONCOLOGY
- Aurora B kinase inhibition in mitosis: Strategies for optimizing the use of Aurora kinase inhibitors such as AT9283
- (2011) Jayne Curry et al. CELL CYCLE
- Phase 1 study of MLN8054, a selective inhibitor of Aurora A kinase in patients with advanced solid tumors
- (2010) E. Claire Dees et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase I Study of the Selective Aurora A Kinase Inhibitor MLN8054 in Patients with Advanced Solid Tumors: Safety, Pharmacokinetics, and Pharmacodynamics
- (2010) T. Macarulla et al. MOLECULAR CANCER THERAPEUTICS
- Pharmacogenetic profiling of Aurora kinase B is associated with overall survival in metastatic colorectal cancer
- (2010) A Pohl et al. PHARMACOGENOMICS JOURNAL
- A phase IB study of ABT-751 in combination with docetaxel in patients with advanced castration-resistant prostate cancer
- (2009) J. Michels et al. ANNALS OF ONCOLOGY
- Expression of Aurora B and alternative variant forms in hepatocellular carcinoma and adjacent tissue
- (2009) Mahmut Yasen et al. CANCER SCIENCE
- A Phase I Dose-Escalation Study of Danusertib (PHA-739358) Administered as a 24-Hour Infusion with and without Granulocyte Colony-Stimulating Factor in a 14-Day Cycle in Patients with Advanced Solid Tumors
- (2009) R. B. Cohen et al. CLINICAL CANCER RESEARCH
- Phase I Pharmacokinetic and Pharmacodynamic Study of the Aurora Kinase Inhibitor Danusertib in Patients With Advanced or Metastatic Solid Tumors
- (2009) Neeltje Steeghs et al. JOURNAL OF CLINICAL ONCOLOGY
- Aurora kinase inhibitors synergize with paclitaxel to induce apoptosis in ovarian cancer cells
- (2009) Christopher D Scharer et al. Journal of Translational Medicine
- Aurora Kinases as Anticancer Drug Targets
- (2008) O. Gautschi et al. CLINICAL CANCER RESEARCH
- Aurora kinase A inhibition and paclitaxel as targeted combination therapy for head and neck squamous cell carcinoma
- (2008) Abhijit Mazumdar et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Fragment-Based Discovery of the Pyrazol-4-yl Urea (AT9283), a Multitargeted Kinase Inhibitor with Potent Aurora Kinase Activity†
- (2008) Steven Howard et al. JOURNAL OF MEDICINAL CHEMISTRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started